Correction to: Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance

被引：0

作者：

Mingzhu He

Marco E. Bianchi

Tom R. Coleman

Kevin J. Tracey

Yousef Al-Abed

机构：

[1] Center for Molecular Innovation,Division of Genetics and Cell Biology, Chromatin Dynamics Unit

[2] The Feinstein Institute for Medical Research,undefined

[3] San Raffaele University and San Raffaele Scientific Institute IRCCS,undefined

[4] Center for Biomedical Science,undefined

[5] and Center for Bioelectronic Medicine,undefined

[6] The Feinstein Institute for Medical Research,undefined

来源：

Molecular Medicine | 2018年 / 24卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

After publication of this article (He et al., 2018), the corresponding authors recognised an error in Scheme 1, in particular to section “A. HMGB1/TLR4/MD-2 complex formation”. Above “Step 2: B box binding to MD-2”, the text incorrectly read: “Low affinity / extremely slow off”. In addition, some text was omitted below “TLR4/MD-2”. The correct version of Scheme 1 is included in this Correction article. The original article (He et al., 2018) has been corrected.

引用

共 50 条

[31] MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4)
Visintin, Alberto
Halmen, Kristen A.
Khan, Naseema
Monks, Brian G.
Golenbock, Douglas T.
Lien, Egil
JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 80 (06) : 1584 - 1592
[32] A designed TLR4/MD-2 complex to capture LPS (vol 11, pg 197, 2005)
Brandl, Katharina
Glueck, Thomas
Hartmann, Pia
Salzberger, Bernd
Falk, Werner
INNATE IMMUNITY, 2012, 18 (04) : 672 - 672
[33] Proinflammatory cytokine HMGB1 increases leptin secretion with a TLR2/TLR4 mechanism in type 2 diabetes related inflammation
Coppola, A.
Capuani, B.
Pacifici, F.
Pastore, D.
Arriga, R.
Rea, S.
Andreadi, A.
Bellia, A.
Tesauro, M.
Della-Morte, D.
Sconocchia, G.
Lauro, D.
DIABETOLOGIA, 2019, 62 : S316 - S316
[34] The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2
Ohnishi, Takahiro
Muroi, Masashi
Tanamoto, Ken-ichi
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2007, 51 (01): : 84 - 91
[35] Correlation of HMGB1, TLR2 and TLR4 with left ventricular diastolic dysfunction in sepsis patients
Lv, Xinwei
Shi, Xiaohui
Maihemuti, Mutalifu
Yang, Danping
Xiao, Dong
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2023, 97 (04)
[36] Radioiodination of an endotoxin•MD-2 complex generates a novel sensitive, high-affinity ligand for TLR4
Teghanemt, Athmane
Weiss, Jerrold P.
Gioannini, Theresa L.
INNATE IMMUNITY, 2013, 19 (05) : 545 - 560
[37] SERUM HMGB1 AND TLR4 LEVELS AS NOVEL BIOLOGICAL MARKERS FOR THE ACTIVITIES OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS
Huang, Q.
Yuan, C.
Ren, H.
Yang, M.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 294 - 294
[38] TLR4/MD-2 and RP105/MD-1 differentially regulate LPS responsiveness in B cells
Nagai, Yoshinori
Ohta, Shoichiro
Miyake, Kensuke
Takatsu, Kiyoshi
JOURNAL OF IMMUNOLOGY, 2009, 182
[39] HMGB1 induces chondrocyte hypertrophy and matrix catabolism via TLR2 and TLR4 signaling in chondrocytes
Bryan, Ru L.
Terkeltaub, Robert
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S873 - S874
[40] Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis
Kawasaki, K
Nogawa, H
Nishijima, M
JOURNAL OF IMMUNOLOGY, 2003, 170 (01): : 413 - 420

← 1 2 3 4 5 →